Clinical Trials Browser

Lung Neoplasms

NCT02264210 2024-09-25

CORIN

Phase 2 Completed

128 enrolled 9 charts

Thoracic

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01996098 2024-09-05

ICTAN

Phase 3 Terminated

251 enrolled

Thoracic

Lung Neoplasms

NCT06517953 2024-07-25

IcomBine

Phase 2 Recruiting

23 enrolled

Thoracic

Non-small Cell Lung Cancer Metastatic

NCT05514314 2022-08-24

A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

Phase 2 Unknown

90 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05132985 2021-12-10

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

Phase 2 Not yet recruiting

45 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05104788 2021-11-03

NeoIpower

Phase 2 Recruiting

27 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03736837 2021-03-15

ALTER-L004

Phase 2 Completed

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04797806 2021-03-15

SAINT

Phase 3 Unknown

206 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02744664 2020-05-27

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Phase 4 Completed

60 enrolled

Thoracic

Lung Neoplasms

NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Phase 3 Unknown

70 enrolled

Thoracic

Non-squamous Non-small Cell Lung Cancer

NCT03983811 2019-06-12

Adjuvant Chemotherapy With or Without Intercalated Icotinib

Phase NA Unknown

174 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03766490 2019-01-30

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

Phase NA Unknown

66 enrolled

Thoracic

Non-Small-Cell Lung

NCT03151161 2018-06-07

Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Phase 2 Unknown

118 enrolled

Thoracic

Lung Neoplasms

NCT01534585 2018-04-17

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Phase 1/2 Completed

48 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01963195 2017-05-08

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

Phase 2 Unknown

30 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT03123484 2017-04-21

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

Phase 2 Unknown

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01724801 2017-03-01

BRAIN

Phase 3 Completed

176 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

Phase 3 Unknown

330 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Phase 4 Unknown

67 enrolled

Thoracic

NSCLC

NCT02738983 2016-04-14

RT Plus EGFR-TKI for Wild-type NSCLC

Phase 2 Unknown

22 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

250 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02375581 2016-03-22

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

Phase 2 Unknown

130 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02430974 2015-04-30

Chemotherapy of NSCLC With or Without Icotinib

Phase 2 Unknown

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02407366 2015-04-02

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Phase 2 Unknown

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Phase 2 Unknown

10 enrolled

Thoracic

Lung Neoplasms

NCT02009605 2015-03-05

Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer

Phase 2 Unknown

30 enrolled

Squamous Cell Carcinoma of Lung

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase 4 Unknown

10 enrolled

Tumor-Agnostic

Neoplasms, Second Primary

NCT02272127 2014-10-22

Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer

Phase 2 Unknown

100 enrolled

Thoracic

NSCLC

NCT02191059 2014-07-31

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Phase 2 Unknown

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01514877 2014-07-23

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Phase 2 Completed

20 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT01688713 2012-09-20

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

Phase 2 Unknown

20 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Clinical Trials

Therapy for Advanced NSCLC With EGFR 19delins Mutation

CORIN

ICTAN

IcomBine

A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

NeoIpower

ALTER-L004

SAINT

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Adjuvant Chemotherapy With or Without Intercalated Icotinib

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

BRAIN

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

Conmana Combined With Thalidomide to Treat NSCLC

RT Plus EGFR-TKI for Wild-type NSCLC

TCL-1

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

Chemotherapy of NSCLC With or Without Icotinib

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer